These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37081725)

  • 41. ABCB1 gene C3435T polymorphism and drug resistance in epilepsy: evidence based on 8,604 subjects.
    Li SX; Liu YY; Wang QB
    Med Sci Monit; 2015 Mar; 21():861-8. PubMed ID: 25799371
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The association between IL-1 family gene polymorphisms and colorectal cancer: A meta-analysis.
    Liu L; Zhai Z; Wang D; Ding Y; Chen X; Wang Q; Shu Z; Wu M; Chen L; He X; Fan D; Pan F; Xing M
    Gene; 2021 Feb; 769():145187. PubMed ID: 32998046
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of the
    Biswas M; Rahaman S; Biswas TK; Ibrahim B
    Expert Opin Drug Saf; 2020 Dec; 19(12):1605-1616. PubMed ID: 33040624
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relationship between multidrug resistance 1 polymorphisms and the risk of prostate cancer in Chinese populations.
    Shen FR; Yan CY; Liu M; Feng YH; Chen YG
    Genet Mol Res; 2013 Sep; 12(3):3806-12. PubMed ID: 24085442
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association between the C3435T polymorphism of ABCB1/MDR1 gene (rs1045642) and colorectal cancer susceptibility : a meta-analysis based on 11,339 subjects.
    Zhao L; Li K; Li W; Yang Z
    Tumour Biol; 2013 Jun; 34(3):1949-57. PubMed ID: 23504525
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Variant genotypes of MDR1 C3435T increase the risk of leukemia: evidence from 10 case-control studies.
    Qian X; Cao S; Yang G; Dong J; Jin G; Shen Y; Hu Z
    Leuk Lymphoma; 2012 Jun; 53(6):1183-7. PubMed ID: 22088099
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association of the MTHFR 677C>T and 1298A>C polymorphisms and male infertility risk: a meta-analysis.
    Aliakbari F; Pouresmaeili F; Eshghifar N; Zolghadr Z; Azizi F
    Reprod Biol Endocrinol; 2020 Sep; 18(1):93. PubMed ID: 32912251
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of MDR1 C3435T and GABRG2 C588T gene polymorphisms in seizure occurrence and MDR1 effect on anti-epileptic drug (phenytoin) absorption.
    Ponnala S; Chaudhari JR; Jaleel MA; Bhiladvala D; Kaipa PR; Das UN; Hasan Q
    Genet Test Mol Biomarkers; 2012 Jun; 16(6):550-7. PubMed ID: 22239287
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multidrug resistance gene 1 C1236T polymorphism and susceptibility to leukemia: A meta-analysis.
    Ma L; Liu H; Ruan L; Yang X; Yang H; Feng Y
    Biomed Rep; 2015 Jan; 3(1):83-87. PubMed ID: 25469253
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Significant association between CYP1A1 T3801C polymorphism and cervical neoplasia risk: a systematic review and meta-analysis.
    Xia L; Gao J; Liu Y; Wu K
    Tumour Biol; 2013 Feb; 34(1):223-30. PubMed ID: 23055196
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MDR1 C3435T polymorphism in patients with breast cancer.
    Turgut S; Yaren A; Kursunluoglu R; Turgut G
    Arch Med Res; 2007 Jul; 38(5):539-44. PubMed ID: 17560460
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association between transforming growth factor-beta 1 T869C polymorphism and ischemic stroke: a meta-analysis.
    Peng L; Li P; Chen J; Yan K; Huo F; Han L; Li C; Tan S; Jiang X
    PLoS One; 2013; 8(7):e67738. PubMed ID: 23861796
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influence of ABCB1 C3435T and C1236T gene polymorphisms on tumour response to docetaxel-based neo-adjuvant chemotherapy in locally advanced breast cancer patients of South India.
    Priyadarshini R; Raj GM; Kayal S; Ramesh A; Shewade DG
    J Clin Pharm Ther; 2019 Apr; 44(2):188-196. PubMed ID: 30637776
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Do polymorphisms in MDR1 and CYP3A5 genes influence the risk of cytogenetic relapse in patients with chronic myeloid leukemia on imatinib therapy?
    Harivenkatesh N; Kumar L; Bakhshi S; Sharma A; Kabra M; Velpandian T; Gogia A; Shastri SS; Gupta YK
    Leuk Lymphoma; 2017 Sep; 58(9):1-9. PubMed ID: 28367681
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of hypoxia inducible factor 1-Alpha gene polymorphisms with multiple disease risks: A comprehensive meta-analysis.
    Harun-Or-Roshid M; Ali MB; Jesmin ; Mollah MNH
    PLoS One; 2022; 17(8):e0273042. PubMed ID: 35972942
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of MDR1 and CYP3A5 genetic polymorphisms on trough levels and therapeutic response of imatinib in newly diagnosed patients with chronic myeloid leukemia.
    Harivenkatesh N; Kumar L; Bakhshi S; Sharma A; Kabra M; Velpandian T; Gogia A; Shastri SS; Biswas NR; Gupta YK
    Pharmacol Res; 2017 Jun; 120():138-145. PubMed ID: 28330783
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association between MDR1 C3435T polymorphism and refractory epilepsy in the Chinese population: a systematic review and meta-analysis.
    Cheng JW; Zhang LJ; Hou YQ; Zhao Q; Zhang XJ; Chen XF; Bai Y
    Epilepsy Behav; 2014 Jul; 36():173-9. PubMed ID: 24953225
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MTHFR 677C>T and 1298A>C polymorphisms and male infertility risk: a meta-analysis.
    Wei B; Xu Z; Ruan J; Zhu M; Jin K; Zhou D; Xu Z; Hu Q; Wang Q; Wang Z
    Mol Biol Rep; 2012 Feb; 39(2):1997-2002. PubMed ID: 21643754
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association of the methylenetetrahydrofolate reductase gene C677T polymorphism with the risk of male infertility: a meta-analysis.
    Zhu X; Liu Z; Zhang M; Gong R; Xu Y; Wang B
    Ren Fail; 2016; 38(2):185-93. PubMed ID: 26584688
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Association between
    BaniHani MN; Khabour OF; Alzoubi KH; Bashir NA; Shakhatreh MAK; Sabi SH; Alrabadi N
    Genes (Basel); 2020 Jan; 11(1):. PubMed ID: 31948121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.